Form 10-Q Pulse Biosciences, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Pulse Biosciences (PLSE) PT Lowered to $43 at H.C. Wainwright
November 16, 2021 6:38 AM ESTH.C. Wainwright analyst Swayampakula Ramakanth lowered the price target on Pulse Biosciences (NASDAQ: PLSE) to $43.00 (from $46.00) while maintaining a Buy rating.
The analyst commented, "Pulse reported 3Q21 financial results and held a conference call on November 15. During the quarter, while Pulse is... More
Pulse Biosciences, Inc. (PLSE) Tops Q3 EPS by 5c
November 15, 2021 5:05 PM ESTPulse Biosciences, Inc. (NASDAQ: PLSE) reported Q3 EPS of ($0.48), $0.05 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $574 thousand versus the consensus estimate of $190 thousand.
For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.
... More